These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 26441397)

  • 1. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
    Rathe JØ
    Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients' concern about their medicine after a generic switch: a combined cross-sectional questionnaire and register study.
    Rathe J; Søndergaard J; Jarbøl DE; Hallas J; Andersen M
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):965-73. PubMed ID: 24946275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study.
    Rathe J; Andersen M; Jarbøl DE; dePont Christensen R; Hallas J; Søndergaard J
    PLoS One; 2015; 10(3):e0119688. PubMed ID: 25775472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between generic substitution and patients' attitudes, beliefs and experiences.
    Rathe J; Larsen P; Andersen M; Paulsen M; Jarbøl D; Thomsen J; Soendergaard J
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1827-36. PubMed ID: 23765409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is associated with increased side effects and lower perceived efficacy following switching to a generic medicine? A New Zealand cross-sectional patient survey.
    MacKrill K; Petrie KJ
    BMJ Open; 2018 Oct; 8(10):e023667. PubMed ID: 30341138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirometry utilisation among Danish adults initiating medication targeting obstructive lung disease.
    Koefoed MM
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2015 Feb; 37(1):68-75. PubMed ID: 25428446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic substitution of antihypertensive drugs: does it affect adherence?
    Van Wijk BL; Klungel OH; Heerdink ER; de Boer A
    Ann Pharmacother; 2006 Jan; 40(1):15-20. PubMed ID: 16303985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact on health outcomes and healthcare utilisation of switching to generic medicines consequent to reference pricing: the case of lamotrigine in New Zealand.
    Lessing C; Ashton T; Davis P
    Appl Health Econ Health Policy; 2014 Oct; 12(5):537-46. PubMed ID: 25005492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
    Kwong WJ; Kamat S; Fang C
    Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort Study.
    Kalaria S; Spence O; Hong K; dosReis S; Gopalakrishnan M
    Clin Pharmacol Ther; 2021 Aug; 110(2):443-451. PubMed ID: 33811324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of substitution among generic drugs on persistence and adherence: A retrospective claims data study from 2 Local Healthcare Units in the Lombardy Region of Italy.
    Colombo GL; Agabiti-Rosei E; Margonato A; Mencacci C; Montecucco CM; Trevisan R; Catapano AL
    Atheroscler Suppl; 2016 Jun; 21():1-8. PubMed ID: 26948872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic substitution of antiepileptic drugs--a survey of patients' perspectives in Germany and other German-speaking countries.
    Hensler K; Uhlmann C; Porschen T; Benecke R; Rösche J
    Epilepsy Behav; 2013 Apr; 27(1):135-9. PubMed ID: 23416284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic substitution: additional challenge for adherence in hypertensive patients?
    Håkonsen H; Eilertsen M; Borge H; Toverud EL
    Curr Med Res Opin; 2009 Oct; 25(10):2515-21. PubMed ID: 19708764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort study.
    Engelkes M; van Blijderveen JC; Overbeek JA; Kuiper J; Herings RCM; Sturkenboom MCJM; de Jongste JC; Verhamme KMC; Janssens HM
    J Asthma; 2018 Oct; 55(10):1086-1094. PubMed ID: 29185812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fifty years old and more patients' attitudes towards and experiences of generic substitution of prescription medicines].
    Ringuier R; Rouquette A; Dagorne C; Garnier F; Fanello S
    Therapie; 2008; 63(1):11-7. PubMed ID: 18387271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
    Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
    Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study.
    Corrao G; Soranna D; Merlino L; Mancia G
    Eur J Clin Invest; 2014 Oct; 44(10):933-9. PubMed ID: 25132063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do users of risperidone who switch brands because of generic reference pricing fare better or worse than non-switchers? A New Zealand natural experiment.
    Lessing C; Ashton T; Davis P
    Adm Policy Ment Health; 2015 Nov; 42(6):695-703. PubMed ID: 25331449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brand name or generic? What are the health professionals prescribed for treating diabetes? A longitudinal analysis of the National Health Insurance reimbursement database.
    Liou WS; Hsieh SC; Chang WY; Wu GH; Huang HS; Lee C
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):752-9. PubMed ID: 23625864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.